Mark Feitelson

Yo, have you heard about Mark Feitelson? Dude’s the real deal in biotech startup land. So, he’s a YC S21 batch guy, meaning he jumped into the startup scene at just the right time, backed by Y Combinator, which is basically the gold standard for startups these days.

But here’s the kicker, his story isn’t just about throwing up a company. Mark’s been deep in the science trenches for ages. He’s got a Ph.D. in Microbiology and Immunology from UCLA, and he started out working on hepatitis B at Stanford, talk about pedigree. This guy’s been around the block, working at places like Temple University, Thomas Jefferson University, Jefferson Hospital, Fox Chase Cancer Center, you name it. Basically, he’s got a resume that reads like a who’s who of top research institutions.

What really gets me is how his research is the backbone of SFA Therapeutics, which he co-founded. The startup’s all about developing treatments for some heavy diseases, especially liver cancer, which is a beast. His work in liver cancer drug development was so effective that it actually drew in Ira Spector to join him and build SFA in 2017. That’s no small feat, he’s been pushing the boundaries of science to make real, tangible cures.

And here’s the thing, this isn’t just about science for Mark. It’s about solving problems that matter. His process from academic research to starting a biotech company shows he’s got that entrepreneurial fire, the kind that says “I see a problem, I know the science, I’m gonna fix it.” It’s like he jumped from the lab bench to the startup world because he genuinely wants to make a difference, no bullshit, just real impact.

Basically, Mark Feitelson is that rare combo of a scientist who’s got the hustle to turn research into something that could save lives. His story? It’s about pushing the limits, about not settling for just publishing papers but actually building stuff that can change the game. That’s why he’s so important, he’s not just another scientist, he’s a builder, a doer, someone who’s out here turning big ideas into real cures. No cap.